THORP CLAY reported 3 transactions at PHASEBIO PHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 11/18/2020ACC: 0001209191-20-059250
Director10% Owner
Since Oct 2018
-39.67K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
12.73K acquired · 52.40K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−52.40K
Price / share
—
Trade value
—
% of position
New position
11/16/2020
52.40K→0.00
Common Stock
Direct
Shares
+2.14K
Price / share
—
Trade value
—
% of position
13.6%
11/16/2020
15.80K→17.94K
Common Stock
Indirect
Shares
+10.59K
Price / share
—
Trade value
—
% of position
218.4%
11/16/2020
4.85K→15.43K
Total
Net shares
−39.67K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/16/2020 | J · J | −52.40K | — | — | New position | 52.40K | 0.00 |
| Common Stock Direct | 11/16/2020 | J · J | +2.14K | — | — | 13.6% | 15.80K | 17.94K |
| Common Stock Indirect | 11/16/2020 | J · J | +10.59K | — | — | 218.4% | 4.85K | 15.43K |
| Total | −39.67K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned415.96K
Common Stock
IndirectShares owned162.89K
Common Stock
IndirectShares owned1.82M
Total
2.40M indirect2.40M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 415.96K | Indirect |
| Common Stock | 162.89K | Indirect |
| Common Stock | 1.82M | Indirect |
| Total | 2.40M | 2.40M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported